The long-term objectives of this proposal are to genetically map with high resolution a recessive mouse mutation that predisposes to the development of polycystic kidney disease. This analysis can presently be expedited using PCR-based strategies, and may serve to identify candidate genes which, when mutated, result in this disease. Genetic mapping has directly facilitated the molecular characterization of a number of human disorders. Examples include cystic fibrosis and neurofibromatosis, for which the identification of flanking markers enabled investigators to identify the mutant gene by positional cloning. Similarly, mapping of the dominant familial cardiac hypertrophy trait to human chromosome 14 served to identify cardiac myosin as a candidate gene for a role in this disease. At present, little is known about the molecular basis of polycystic disease. One locus has been identified on human chromosome 16 which appears responsible for the development of dominantly inherited polycystic disease, and efforts to clone this gene are in progress. Linkage analysis for the localization of the genes which cause recessively-inherited polycystic disease is presently not feasible, due to the early lethality and relative rarity of this disorder. An alternative approach to the identification of genes that predispose to polycystic kidney diseases may potentially be accomplished by the study of mouse mutations. There are at least five mutations which cause polycystic kidneys: cpk (congenital polycystic kidney), pcy (progressive cystic kidney), spk (spongy kidney), 1330 (not named), and jck (juvenile cystic kidney). This last mutation is one that I have discovered and am presently characterizing. Recent developments in genetic analysis and molecular techniques make it technically feasible to map the jck trait with high resolution. This will be done using PCR-based analysis of its linkage with genetic markers in a cross between inbred laboratory strains (C57B1/6J and DBA/2J) and in an interspecific cross between C57B1/6J and M. castaneus mice. This mapping analysis may identify candidate genes that are responsible for the development of polycystic kidney disease. These candidate loci can then be tested for abnormalities using molecular techniques such as SSCP (single-strand conformer polymorphism) analysis to assess if these genes are mutant in the jck mice.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK045639-03
Application #
2144841
Study Section
General Medicine B Study Section (GMB)
Project Start
1992-09-30
Project End
1995-09-29
Budget Start
1994-09-30
Budget End
1995-09-29
Support Year
3
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02115
Beier, David R (2016) High-resolution genetic localization of a modifying locus affecting disease severity in the juvenile cystic kidneys (jck) mouse model of polycystic kidney disease. Mamm Genome 27:191-9
Liu, Shanming; Lu, Weining; Obara, Tomoko et al. (2002) A defect in a novel Nek-family kinase causes cystic kidney disease in the mouse and in zebrafish. Development 129:5839-46
Guay-Woodford, L M; Green, W J; Lindsey, J R et al. (2000) Germline and somatic loss of function of the mouse cpk gene causes biliary ductal pathology that is genetically modulated. Hum Mol Genet 9:769-78
Kuida, S; Beier, D R (2000) Genetic localization of interacting modifiers affecting severity in a murine model of polycystic kidney disease. Genome Res 10:49-54
Cohen, D E; Green, R M; Wu, M K et al. (1999) Cloning, tissue-specific expression, gene structure and chromosomal localization of human phosphatidylcholine transfer protein. Biochim Biophys Acta 1447:265-70
Marks, P W; Bandura, J L; Shieh, D B et al. (1999) The spontaneous coat color mutant white nose (wn) maps to murine chromosome 15. Mamm Genome 10:750-2
Green, R M; Lo, K; Sterritt, C et al. (1999) Cloning and functional expression of a mouse liver organic cation transporter. Hepatology 29:1556-62
Deak, F; Mates, L; Krysan, K et al. (1999) Characterization and chromosome location of the mouse link protein gene (Crtl1). Cytogenet Cell Genet 87:75-9
Brady, K P; Dushkin, H; Fornzler, D et al. (1999) A novel putative transporter maps to the osteosclerosis (oc) mutation and is not expressed in the oc mutant mouse. Genomics 56:254-61
Iakoubova, O; Dushkin, H; Pacella, L et al. (1999) Genetic analysis of modifying loci on mouse chromosome 1 that affect disease severity in a model of recessive PKD. Physiol Genomics 1:101-5

Showing the most recent 10 out of 17 publications